Are CD44⁺/CD24⁻ cells the assumed cancer stem cells in breast cancer?

• Veröffentlicht in: Experimental Oncology
• Datum: 2017
• Hauptverfasser: Ryspayeva, D.E., Smolanka, I.I., Dudnichenko, A.S., Lyashenko, A.A., Grinevich, Yu.A., Gurianov, V.G., Koshubarova, M.V., Seleznev, A.A.
• Format: Artikel
• Sprache: English
• Veröffentlicht: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2017
• Schlagworte: Original contributions
• Online Zugang: https://nasplib.isofts.kiev.ua/handle/123456789/138542
• Назва журналу: Digital Library of Periodicals of National Academy of Sciences of Ukraine
• Zitieren: Are CD44⁺/CD24⁻ cells the assumed cancer stem cells in breast cancer? / D.E. Ryspayeva, I.I. Smolanka, A.S. Dudnichenko, A.A. Lyashenko, Yu.A. Grinevich, V.G. Gurianov, M.V. Koshubarova, A.A. Seleznev // Experimental Oncology. — 2017 — Т. 39, № 3. — С. 224–228. — Бібліогр.: 20 назв. — англ.

Identification and characterization of the population of cancer stem cells (CSC) depends on several cellular markers, which combination is specific for the phenotype of CSC in the corresponding tumor. Several markers of CSC have already been identified in breast cancer (BC), but there are no univers...